[go: up one dir, main page]

ES2137538T3 - Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores. - Google Patents

Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores.

Info

Publication number
ES2137538T3
ES2137538T3 ES95930671T ES95930671T ES2137538T3 ES 2137538 T3 ES2137538 T3 ES 2137538T3 ES 95930671 T ES95930671 T ES 95930671T ES 95930671 T ES95930671 T ES 95930671T ES 2137538 T3 ES2137538 T3 ES 2137538T3
Authority
ES
Spain
Prior art keywords
tumors
proteins
activity
analysis method
biological samples
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95930671T
Other languages
English (en)
Inventor
Balazs Sarkadi
Laszlo Homolya
Zsolt Hollo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2137538T3 publication Critical patent/ES2137538T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/807—Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808—Automated or kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBE AQUI UN METODO DE ENSAYO DE DIAGNOSTICO Y KITS DE REACTIVO PARA LA DETERMINACION CUANTITATIVA IN VITRO DE LA ACTIVIDAD EN ESPECIMENES BIOLOGICOS DE PROTEINAS MDR QUE CAUSAN RESISTENCIA A MULTIPLES FARMACOS EN TUMORES. EL METODO DE LA INVENCION ESTA BASADO EN LA MEDICION DE LA VELOCIDAD DE ACUMULACION DE UN COMPUESTO EN LAS CELULAS DEL ESPECIMEN (VENTAJOSAMENTE MEDIANTE MEDICION DE FLUORESCENCIA); DICHO COMPUESTO NO ES UN BUEN SUSTRATO DE LA PROTEINA MDR PRESENTE EN LA MUESTRA, NO PERMEABLE A LA CELULA Y ESTA SIENDO FORMADO EN LAS CELULAS, MEDIANTE ENZIMAS GENERALMENTE PRESENTES EN LAS CELULAS, A PARTIR DE UN COMPUESTO QUE ES UN BUEN SUSTRATO DE DICHA PROTEINA MDR, PERMEABLE A LA CELULA Y SE AÑADE AL ESPECIMEN IN VITRO. BASADO EN EL METODO DE LA INVENCION, ES POSIBLE CALCULAR UN VALOR DEL FACTOR DE ACTIVIDAD DE MDR (MAF) QUE ES, EN EL RANGO DE DIAGNOSTICO RELEVANTE, CARACTERISTICO DE LA ACTIVIDAD MDR, ES DECIR, AL NIVEL DE RESISTENCIA A MULTIPLES FARMACOS DEL ESPECIMEN.
ES95930671T 1994-08-31 1995-08-31 Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores. Expired - Lifetime ES2137538T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9402511A HU217108B (hu) 1994-08-31 1994-08-31 Eljárás daganatok multidrogrezisztenciáját okozó fehérje aktivitásának in vitro mennyiségi kimutatására biológiai mintákban

Publications (1)

Publication Number Publication Date
ES2137538T3 true ES2137538T3 (es) 1999-12-16

Family

ID=10985550

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95930671T Expired - Lifetime ES2137538T3 (es) 1994-08-31 1995-08-31 Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores.

Country Status (7)

Country Link
US (1) US5872014A (es)
EP (1) EP0784699B1 (es)
AT (1) ATE182179T1 (es)
DE (1) DE69510809T2 (es)
ES (1) ES2137538T3 (es)
HU (1) HU217108B (es)
WO (1) WO1996006945A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042079A1 (en) * 1994-02-01 2002-04-11 Sanford M. Simon Methods and agents for measuring and controlling multidrug resistance
US6277655B1 (en) 1994-10-13 2001-08-21 Solvo Biotechnology Assay and reagent kit for evaluation of multi-drug resistance in cells
US6162616A (en) * 1997-04-16 2000-12-19 Millennium Pharmaceuticals, Inc. Multidrug resistance-associated polypeptide
HUP0002557A3 (en) * 2000-07-03 2004-08-30 Solvo Biotechnologiai Kft Simple quantitative fluorescent assay method for determining the activity of transport proteins of interest
JP2004510961A (ja) * 2000-09-15 2004-04-08 ビルコ・ビーブイビーエイ 疾患の処置のための薬物療法を最適化するシステムおよび方法
US20030036049A1 (en) * 2001-01-03 2003-02-20 Medis El Ltd. Optical method for testing sensitivity of cells
WO2003027264A2 (en) * 2001-09-27 2003-04-03 University Of Delaware Coisogenic eukaryotic cell collections
HUP0700042A2 (en) * 2004-05-25 2009-03-02 Solvo Biotechnologiai Zrt Method and reagent kit for evaluation of multidrug-resistance activity
US7795019B2 (en) 2006-11-10 2010-09-14 Absorption Systems Group, Llc Stable cell lines and methods for evaluating gastrointestinal absorption of chemicals
US7838256B2 (en) 2007-02-23 2010-11-23 Board Of Regents Of The University Of Nebraska Assay and kit for drug efflux transporter activity
US8445271B2 (en) 2010-05-03 2013-05-21 Enzo Life Sciences, Inc. Processes and kits for determining multi-drug resistance of cells
HU231387B1 (hu) 2017-10-25 2023-06-28 Cellpharma Kft. Fluoreszcens festékfelhalmozódási vizsgálat
EP3570028A1 (en) 2018-05-15 2019-11-20 MDQuest Kft. Assessing responsiveness of rheumatoid arthritis patients to biological treatment
US20210382049A1 (en) 2018-05-15 2021-12-09 Navolab Diagnosztika Kft. Assessing responsiveness of rheumatoid arthritis patients to biological treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
US5407653A (en) * 1991-06-26 1995-04-18 Brigham And Women's Hospital Evaluation of the multidrug resistance phenotype
US5314805A (en) * 1991-10-28 1994-05-24 Molecular Probes, Inc. Dual-fluorescence cell viability assay using ethidium homodimer and calcein AM

Also Published As

Publication number Publication date
HU217108B (hu) 1999-11-29
HUT72700A (en) 1996-05-28
ATE182179T1 (de) 1999-07-15
US5872014A (en) 1999-02-16
EP0784699B1 (en) 1999-07-14
DE69510809T2 (de) 2000-03-16
EP0784699A1 (en) 1997-07-23
HU9402511D0 (en) 1994-10-28
WO1996006945A1 (en) 1996-03-07
DE69510809D1 (de) 1999-08-19

Similar Documents

Publication Publication Date Title
Russell Clinical relevance of polyamines as biochemical markers of tumor kinetics.
Kassie et al. Single cell gel electrophoresis assay: a new technique for human biomonitoring studies
ES2137538T3 (es) Metodo de analisis y kit de reactivos para la determinacion cuantitativa in vitro, en muestras biologicas, de la actividad de proteinas que causan resistencia a multiples farmacos en tumores.
EP0200507B1 (en) Improved enzyme immunoassay and a kit therefor
DK221090A (da) Fremgangsmaade og apparat til diagnostisk analyse ved stroemmaaling
GR3007117T3 (es)
CA2557568C (en) Pharmacodynamic assays using flow cytometry
DE59914830D1 (de) Verfahren und testbesteck zur beurteilung der oxid messung ihrer antiradikalen aktivität
Livaniou et al. Serum biotin levels in patients undergoing chronic hemodialysis
EP1159614A4 (en) DIAGNOSTIC METHOD FOR ASTHMA
KR101138343B1 (ko) 알츠하이머 질병의 진단을 위한 신속한 시험법
Beutler et al. Incidence of the erythrocytic defect associated with drug-sensitivity among oriental subjects
Al-Khalidi et al. A method for the determination of plasma guanase on finger-tip blood
Eichhorn et al. Fluorometric method for quantitatively estimating urinary dihydroxyphenylethylamine (dopamine), dihydroxyphenylalanine (dopa), and dihydroxyphenylacetic acid (dopac)
Rogers et al. Simultaneous evaluation of pancreatic exocrine function and intestinal absorptive function in dogs with chronic diarrhea
US20170176413A1 (en) Pharmacodynamic assays
US9404931B2 (en) Measurement of cytoskeletal proteins and uses thereof in diagnosis, prognosis and therapy
RU2178563C1 (ru) Способ прогнозирования преморбидного состояния при воздействии химических загрязнителей производственной среды
Johnson et al. Rapid spectrophotometric assay of serum iron
Governa et al. Chemotactic activity of human polymorphonuclear leukocytes and industrial xenobiotics: a brief review
RU2196991C2 (ru) Способ диагностики микст-инфекций при воспалительных заболеваниях уретры и предстательной железы
RU95111009A (ru) Способ выявления сенсибилизации к лекарственным аллергенам
RU2323443C1 (ru) Способ оценки эффективности лечения аутоиммунного тиреоидита
Rinaldo et al. Comparison of urinary acylglycines and acylcarnitines as diagnostic markers of medium-chain acyl-CoA dehydrogenase deficiency
CZ2017272A3 (cs) Diagnostický proužek pro stanovení množství sarkosinu, kreatininu a peroxidu vodíku v biologickém nebo environmentálním vzorku

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 784699

Country of ref document: ES